Shijie Xu - Search Results

Year	Number of Results
2002	3
2003	7
2004	9
2005	6
2006	4
2007	3
2008	2
2009	2
2010	1
2011	3
2012	3
2013	5
2014	4
2015	5
2016	4
2017	7
2018	8
2019	14
2020	22
2021	26
2022	24
2023	26
2024	9

1

AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia.

Nawaz W, Huang B, Xu S, Li Y, Zhu L, Yiqiao H, Wu Z, Wu X. Nawaz W, et al. Among authors: xu s. Blood Cancer J. 2021 Jun 23;11(6):119. doi: 10.1038/s41408-021-00508-1. Blood Cancer J. 2021. PMID: 34162832 Free PMC article.

2

Challenges and opportunities in C1-based biomanufacturing.

Qiao W, Xu S, Liu Z, Fu X, Zhao H, Shi S. Qiao W, et al. Among authors: xu s. Bioresour Technol. 2022 Nov;364:128095. doi: 10.1016/j.biortech.2022.128095. Epub 2022 Oct 8. Bioresour Technol. 2022. PMID: 36220528 Review.

3

Characteristics of MK-801-induced locomotor sensitization.

Li G, Xu S, Kang UG. Li G, et al. Among authors: xu s. Biochem Biophys Res Commun. 2023 Jul 30;667:18-24. doi: 10.1016/j.bbrc.2023.05.009. Epub 2023 May 11. Biochem Biophys Res Commun. 2023. PMID: 37201359

4

Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8⁺-T cell immunity.

Liu F, Zhou Q, Jiang HF, Zhang TT, Miao C, Xu XH, Wu JX, Yin SL, Xu SJ, Peng JY, Gao PP, Cao X, Pan F, He X, Chen XQ. Liu F, et al. J Exp Clin Cancer Res. 2023 May 10;42(1):118. doi: 10.1186/s13046-023-02686-1. J Exp Clin Cancer Res. 2023. PMID: 37161450 Free PMC article.

5

COVID-19 and trained immunity: the inflammatory burden of long covid.

Gu J, Liu Q, Zhang J, Xu S. Gu J, et al. Among authors: xu s. Front Immunol. 2023 Nov 28;14:1294959. doi: 10.3389/fimmu.2023.1294959. eCollection 2023. Front Immunol. 2023. PMID: 38090572 Free PMC article.

6

Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy.

Nawaz W, Xu S, Li Y, Huang B, Wu X, Wu Z. Nawaz W, et al. Among authors: xu s. Acta Biomater. 2020 Jun;109:21-36. doi: 10.1016/j.actbio.2020.04.015. Epub 2020 Apr 13. Acta Biomater. 2020. PMID: 32294554 Review.

7

Engineering propionyl-CoA pools for de novo biosynthesis of odd-chain fatty acids in microbial cell factories.

Qiao W, Dong G, Xu S, Li L, Shi S. Qiao W, et al. Among authors: xu s. Crit Rev Biotechnol. 2023 Dec;43(7):1063-1072. doi: 10.1080/07388551.2022.2100736. Epub 2022 Aug 22. Crit Rev Biotechnol. 2023. PMID: 35994297 Review.

8

Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody.

Ji M, Hu J, Zhang D, Huang B, Xu S, Jiang N, Chen Y, Wang Y, Wu X, Wu Z. Ji M, et al. Among authors: xu s. EMBO Mol Med. 2024 Mar;16(3):575-595. doi: 10.1038/s44321-024-00026-0. Epub 2024 Feb 16. EMBO Mol Med. 2024. PMID: 38366162 Free PMC article.

9

Triple Stimuli-Responsive Flexible Shape Memory Foams with Super-Amphiphilicity.

Ding X, Shi Y, Xu S, Zhang Y, Du J, Qiu J. Ding X, et al. Among authors: xu s. Small. 2023 Feb;19(6):e2205797. doi: 10.1002/smll.202205797. Epub 2022 Dec 3. Small. 2023. PMID: 36461700

10

Synthesis of Deliquescent Lithium Sulfide in Air.

Yang S, Hu X, Xu S, Han A, Zhang X, Zhang N, Chen X, Tian R, Song D, Yang Y. Yang S, et al. Among authors: xu s. ACS Appl Mater Interfaces. 2023 Aug 30;15(34):40633-40647. doi: 10.1021/acsami.3c08506. Epub 2023 Aug 15. ACS Appl Mater Interfaces. 2023. PMID: 37581568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

176 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Results by year